Life Science Leader Magazine Supplements

CMO Leadership Awards 2013

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/183480

Contents of this Issue

Navigation

Page 43 of 69

2013 CMO Leadership Awards Winner Profiles DRUG TYPE: Biopharmaceuticals PARAGON BIOSERVICES, Inc. Baltimore, MD Manufacturing locations: Baltimore, MD www.paragonbioservices.com (410) 975-4050 Contacts: Philip Wills pwills@paragonbioservices.com Tarran Pierfelice, Ph.D. tpierfelice@paragonbioservices.com DRUG LIFE CYCLE STAGES: Research & Development — discovery, preclinical, clinical (phase 1 and phase 2); Drug Substance Production — primary process development and drug substance production; Formulated Drug Production — dosage form production and packaging SERVICES OFFERED: Aseptic fill/finish, injectables, liquids, proteins, sterile, and vaccines. "Paragon Bioservices has a top-notch team of scientists and engineers with decades of collective experience working with biologics — from research services and process development to GMP manufacturing. For more than twenty years, we have helped pharmaceutical companies, biotechnology companies, and government agencies (DoD, NIH) move forward in the development of viral vectors, vaccines, and VLPs — as well as the production and purification of monoclonal antibodies and recombinant proteins." — Marco Chacón, CEO DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Patheon Durham, NC Manufacturing locations: Canada, France, Italy, United Kingdom, and United States www.patheon.com (919) 226-3200 Contact: Joe Principe Joe.Principe@Patheon.com DRUG LIFE CYCLE STAGES: Research & Development — preclinical, clinical (phase 1, phase 2, and phase 3); Drug Substance Production — primary process development Formulated Drug Production — dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, capsules, cartridges, controlled substances, cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, nonsterile, OTC, parenterals (large volume), parenterals (small volume), powders (nonsterile), powders (sterile), soft gels, solid dose, solutions & suspensions, sterile, sustained release, and syringes (prefilled). "Every day at Patheon we are committed to providing our clients with the industry's leading customer experience. Quality, reliability, innovation, and productivity are cornerstones to our vision, and it is rewarding to be recognized for the third consecutive year by our customers and the industry. It is because of our customers that we are able to improve the quality of life for patients, and it is because of our employees that we help them excel." — Jim Mullen, CEO DRUG TYPE: Pharmaceuticals Penn Pharmaceutical Services Limited Tredegar, Gwent, United Kingdom Manufacturing locations: Tredegar, Gwent, United Kingdom www.pennpharm.com 01495 711222 Contact: Joanne Phelps joanne.phelps@pennpharm.com DRUG LIFE CYCLE STAGES: Research & Development — clinical (phase 1, phase 2, and phase 3); Formulated Drug Production — dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Capsules, controlled substances, creams & ointments, cytotoxic & high-potency compounds, gels, generics, liquids, nonsterile, OTC, powders (nonsterile), semisolids, solid dose, solutions & suspensions, sustained release, and topicals. "Penn constantly listens to its customers to hear what they need today, and what they think they will need tomorrow. We then invest in the capacity and capabilities to support those market needs. Alongside this, staff are trained and developed to ensure we can deliver great performance across our range of services. A culture of continuous improvement has been instilled in the organization, and this drives superior delivery, quality, and value to the benefit of our customers." — Richard Yarwood, CEO 42 The CMO Leadership Awards 2013

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO Leadership Awards 2013